Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Mutch

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Procedures

Anatomy

Cultured Tumor Cells

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Nugent Elizabeth K; Zighelboim Israel; Case Ashley S; Gao Feng; Thaker Premal H; Rader Janet S; Mutch David G; Massad L Stewart
The value of perioperative imaging in patients with uterine sarcomas.
Hu Xiaoxia; Macdonald Dusten M; Huettner Phyllis C; Feng Zhihui; El Naqa Issam M; Schwarz Julie K; Mutch David G; Grigsby Perry W; Powell Simon N; Wang Xiaowei
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Varley Katherine E; Mutch David G; Edmonston Tina B; Goodfellow Paul J; Mitra Robi D
Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Mutch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nugent Elizabeth K; Zighelboim Israel; Case Ashley S; Gao Feng; Thaker Premal H; Rader Janet S; Mutch David G; Massad L Stewart
The value of perioperative imaging in patients with uterine sarcomas.
Gynecologic oncology 2009;115(1):37-40.
2009: Hu Xiaoxia; Macdonald Dusten M; Huettner Phyllis C; Feng Zhihui; El Naqa Issam M; Schwarz Julie K; Mutch David G; Grigsby Perry W; Powell Simon N; Wang Xiaowei
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Gynecologic oncology 2009;114(3):457-64.
2009: Varley Katherine E; Mutch David G; Edmonston Tina B; Goodfellow Paul J; Mitra Robi D
Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing.
Nucleic acids research 2009;37(14):4603-12.
2009: Zighelboim Israel; Schmidt Amy P; Gao Feng; Thaker Premal H; Powell Matthew A; Rader Janet S; Gibb Randall K; Mutch David G; Goodfellow Paul J
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3091-6.
2008: Herzog Thomas J; Powell Matthew A; Rader Janet S; Gibb Randall K; Lippmann Lynne; Coleman Robert L; Mutch David G
Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer.
Gynecologic oncology 2008;111(3):467-73.
2008: Nguyen T T; Wright J D; Powell M A; Gibb R K; Rader J S; Allsworth J E; Mutch D G
Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(6):1194-9.
2008: Wright Jason D; Tian Chunqiao; Mutch David G; Herzog Thomas J; Nagao Shoji; Fujiwara Keiichi; Powell Matthew A
Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 2008;109(3):353-8.
2008: Wright J D; Secord A A; Numnum T M; Rocconi R P; Powell M A; Berchuck A; Alvarez R D; Gibb R K; Trinkaus K; Rader J S; Mutch D G
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(3):400-6.
2008: Case Ashley S; Zighelboim Israel; Mutch David G; Babb Sheri A; Schmidt Amy P; Whelan Alison J; Thibodeau Stephen N; Goodfellow Paul J
Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.
Gynecologic oncology 2008;108(2):438-44.
2007: Zhang Zhengyan; Borecki Ingrid; Nguyen Loan; Ma Duanduan; Smith Kimberly; Huettner Phyllis C; Mutch David G; Herzog Thomas J; Gibb Randall K; Powell Matthew A; Grigsby Perry W; Massad L Stewart; Hernandez Enrique; Judson Patricia L; Swisher Elizabeth M; Crowder Sara; Li Jianduan; Gerhard Daniela S; Rader Janet S
CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
Cancer research 2007;67(23):11202-8.
2007: Horowitz Neil S; Hua Jun; Powell Matthew A; Gibb Randall K; Mutch David G; Herzog Thomas J
Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
Gynecologic oncology 2007;107(2):344-9.
2007: Wright Jason D; Grigsby Perry W; Rader Janet S; Mutch David G; Powell Matthew A; Gao Feng; Gibb Randall K
Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer.
Gynecologic oncology 2007;107(2):280-4.
2007: Wright Jason D; Powell Matthew A; Rader Janet S; Mutch David G; Gibb Randall K
Bevacizumab therapy in patients with recurrent uterine neoplasms.
Anticancer research 2007;27(5B):3525-8.
2007: Wright Jason D; Grigsby Perry W; Brooks Rebecca; Powell Matthew A; Gibb Randall K; Gao Feng; Rader Janet S; Mutch David G
Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
Cancer 2007;110(6):1281-6.
2007: Mutch David G; Orlando Mauro; Goss Tiana; Teneriello Michael G; Gordon Alan N; McMeekin Scott D; Wang Yanping; Scribner Dennis R; Marciniack Martin; Naumann R Wendel; Secord Angeles Alvarez
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2811-8.
2007: Lin Lilie L; Mutch David G; Rader Janet S; Powell Matthew A; Grigsby Perry W
External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
Gynecologic oncology 2007;106(1):215-20.
2007: Huh W K; Straughn J M; Mariani A; Podratz K C; Havrilesky L J; Alvarez-Secord A; Gold M A; McMeekin D S; Modesitt S; Cooper A L; Powell M A; Mutch D G; Nag S; Alvarez R D; Cohn D E
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(4):886-9.
2007: Leath Charles A; Huh Warner K; Hyde Johnny; Cohn David E; Resnick Kimberly E; Taylor Nicholas P; Powell Matthew A; Mutch David G; Bradley William H; Geller Melissa A; Argenta Peter A; Gold Michael A
A multi-institutional review of outcomes of endometrial stromal sarcoma.
Gynecologic oncology 2007;105(3):630-4.
2007: Zighelboim Israel; Goodfellow Paul J; Gao Feng; Gibb Randall K; Powell Matthew A; Rader Janet S; Mutch David G
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2042-8.
2007: Zighelboim Israel; Goodfellow Paul J; Schmidt Amy P; Walls Ken C; Mallon Mary Ann; Mutch David G; Yan Pearlly S; Huang Tim Hui-Ming; Powell Matthew A
Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2882-9.
2007: Zighelboim Israel; Babb Sheri; Gao Feng; Powell Matthew A; Mutch David G; Goodfellow Paul J
Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility.
Gynecologic oncology 2007;105(2):390-4.
2007: Chen Huiping; Taylor Nicholas P; Sotamaa Kaisa M; Mutch David G; Powell Matthew A; Schmidt Amy P; Feng Sheng; Hampel Heather L; de la Chapelle Albert; Goodfellow Paul J
Evidence for heritable predisposition to epigenetic silencing of MLH1.
International journal of cancer. Journal international du cancer 2007;120(8):1684-8.
2007: Mutch David G; Powell Matthew A; Allsworth Jenifer E; Taylor Nicholas P; Brooks Rebecca A
How accurate is Pipelle sampling: a study by Huang et al.
American journal of obstetrics and gynecology 2007;196(3):280-1.
2007: Mutch David G; Powell Matthew A; Allsworth Jenifer E; Taylor Nicholas P; Brooks Rebecca A
Discussion: 'Accuracy of preoperative endometrial sampling' by Huang et al.
American journal of obstetrics and gynecology 2007;196(3):e1-6.
2007: Shim Tammy L; Wright Jason D; Rubin Brian G; Mutch David G
A vascular graft for endometrial cancer groin recurrence.
Gynecologic oncology 2007;104(3):753-6.
2007: McCourt Carolyn K; Mutch David G; Gibb Randall K; Rader Janet S; Goodfellow Paul J; Trinkaus Kathryn; Powell Matthew A
Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer.
Gynecologic oncology 2007;104(3):535-9.
2007: Fayed Alaa; Mutch David G; Rader Janet S; Gibb Randall K; Powell Matthew A; Wright Jason D; Elnaqa Issam; Zoberi Imran; Grigsby Perry W
Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
International journal of radiation oncology, biology, physics 2007;67(2):480-4.
2006: Buttin B M; Powell M A; Goodfellow P J; Lewin S N; Gibb R K; Mutch D G
Increased risk for abnormalities on perioperative colon screening in patients with microsatellite instability-positive endometrial carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(6):1980-6.
2006: Zighelboim Israel; Taylor Nicholas P; Powell Matthew A; Gibb Randall K; Rader Janet S; Mutch David G; Grigsby Perry W
Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy.
Radiation medicine 2006;24(9):625-30.
2006: Herzog Thomas J; Powell Matthew A; Rader Janet S; Gibb Randall; Mutch David G
Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer.
Gynecologic oncology 2006;103(2):637-41.
2006: Wright Jason D; Viviano Dana; Powell Matthew A; Gibb Randall K; Mutch David G; Grigsby Perry W; Rader Janet S
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
Gynecologic oncology 2006;103(2):489-93.
2006: Taylor Nicholas P; Zighelboim Israel; Huettner Phyllis C; Powell Matthew A; Gibb Randall K; Rader Janet S; Mutch David G; Edmonston Tina B; Goodfellow Paul J
DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(10):1333-8.
2006: Gossner Gabrielle; Coleman Robert L; Mutch David G; Horowitz Neil S; Rader Janet S; Gibb Randall K; Powell Matthew A; Herzog Thomas J
CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan.
Gynecologic oncology 2006;103(1):212-8.
2006: Taylor Nicholas P; Powell Matthew A; Gibb Randall K; Rader Janet S; Huettner Phyllis C; Thibodeau Stephen N; Mutch David G; Goodfellow Paul J
MLH3 mutation in endometrial cancer.
Cancer research 2006;66(15):7502-8.
2006: Brooks Rebecca A; Mutch David G
Gene therapy in gynecological cancer.
Expert review of anticancer therapy 2006;6(7):1013-32.
2006: Wright Jason D; Hagemann Andrea; Rader Janet S; Viviano Dana; Gibb Randall K; Norris Lori; Mutch David G; Powell Matthew A
Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.
Cancer 2006;107(1):83-9.
2006: Wright Jason D; Rosenbush Emily J; Powell Matthew A; Rader Janet S; Mutch David G; Gao Feng; Gibb Randall K
Long-term outcome of women who undergo panniculectomy at the time of gynecologic surgery.
Gynecologic oncology 2006;102(1):86-91.
2006: Wright Jason D; Rader Janet S; Davila Rosa; Powell Matthew A; Mutch David G; Gao Feng; Gibb Randall K
Human papillomavirus triage for young women with atypical squamous cells of undetermined significance.
Obstetrics and gynecology 2006;107(4):822-9.
2006: Rutledge Teresa L; Gold Michael A; McMeekin D Scott; Huh Warner K; Powell Matthew A; Lewin Sharyn N; Mutch David G; Johnson Gary A; Walker Joan L; Mannel Robert S
Carcinosarcoma of the ovary-a case series.
Gynecologic oncology 2006;100(1):128-32.
2006: Taylor Nicholas P; Gibb Randall K; Powell Matthew A; Mutch David G; Huettner Phyllis C; Goodfellow Paul J
Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomas.
Gynecologic oncology 2006;100(1):107-10.
2005: Wright Jason D; Dehdashti Farrokh; Herzog Thomas J; Mutch David G; Huettner Phyllis C; Rader Janet S; Gibb Randall K; Powell Matthew A; Gao Feng; Siegel Barry A; Grigsby Perry W
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
Cancer 2005;104(11):2484-91.
2005: Lewin Sharyn N; Buttin Barbara M; Powell Matthew A; Gibb Randall K; Rader Janet S; Mutch David G; Herzog Thomas J
Resource utilization for ovarian cancer patients at the end of life: how much is too much?
Gynecologic oncology 2005;99(2):261-6.
2005: Wright Jason D; Rosenblum Keren; Huettner Phyllis C; Mutch David G; Rader Janet S; Powell Matthew A; Gibb Randall K
Cervical sarcomas: an analysis of incidence and outcome.
Gynecologic oncology 2005;99(2):348-51.
2005: Lin Lilie L; Grigsby Perry W; Powell Matthew A; Mutch David G
Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer.
International journal of radiation oncology, biology, physics 2005;63(2):500-4.
2005: Wright Jason D; Powell Matthew A; Mutch David G; Rader Janet S; Gibb Randall K; Gao Feng; Herzog Thomas J
Relationship of ovarian neoplasms and body mass index.
The Journal of reproductive medicine 2005;50(8):595-602.
2005: Kirby Tyler O; Rocconi Rodney P; Numnum T Michael; Kendrick James E; Wright Jason; Fowler Wiley; Mutch David G; Bhoola Snehal M; Huh Warner K; Straughn J Michael
Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy.
Gynecologic oncology 2005;98(2):309-12.
2005: Wright Jason D; Davila Rosa M; Pinto Karen R; Merritt Diane F; Gibb Randall K; Rader Janet S; Mutch David G; Gao Feng; Powell Matthew A
Cervical dysplasia in adolescents.
Obstetrics and gynecology 2005;106(1):115-20.
2005: Lamoreaux Wayne T; Grigsby Perry W; Dehdashti Farrokh; Zoberi Imran; Powell Matthew A; Gibb Randall K; Rader Janet S; Mutch David G; Siegel Barry A
FDG-PET evaluation of vaginal carcinoma.
International journal of radiation oncology, biology, physics 2005;62(3):733-7.
2005: Hua Jun; Mutch David G; Herzog Thomas J
Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
Gynecologic oncology 2005;98(1):31-8.
2005: Wright Jason D; Li Jianduan; Gerhard Daniela S; Zhang Zhengyan; Huettner Phyllis C; Powell Matthew A; Gibb Randall K; Herzog Thomas J; Mutch David G; Trinkaus Kathryn M; Rader Janet S
Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma.
Gynecologic oncology 2005;98(1):84-91.
2005: Lewin Sharyn N; Mutch David G; Whitcomb Bradford P; Liapis Helen; Herzog Thomas J
Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin.
Gynecologic oncology 2005;97(1):228-33.
2005: Singh Anurag K; Grigsby Perry W; Rader Janet S; Mutch David G; Powell Matthew A
Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence.
International journal of radiation oncology, biology, physics 2005;61(2):450-5.
2005: Grigsby Perry W; Mutch David G; Rader Janet; Herzog Thomas J; Zoberi Imran; Siegel Barry A; Dehdashti Farrokh
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.
International journal of radiation oncology, biology, physics 2005;61(2):444-9.
2005: Wright Jason D; Gibb Randall K; Geevarghese Sajeena; Powell Matthew A; Herzog Thomas J; Mutch David G; Grigsby Perry W; Gao Feng; Trinkaus Kathryn M; Rader Janet S
Cervical carcinoma in the elderly: an analysis of patterns of care and outcome.
Cancer 2005;103(1):85-91.
2004: Horowitz Neil S; Dehdashti Farrokh; Herzog Thomas J; Rader Janet S; Powell Matthew A; Gibb Randal K; Grigsby Perry W; Siegel Barry A; Mutch David G
Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Gynecologic oncology 2004;95(3):546-51.
2004: Ogunleye Dele A; Lewin Sharyn N; Mutch David G; Liapis Helen; Herzog Thomas J
Hemolytic uremic syndrome presenting after treatment of endodermal sinus tumor.
Obstetrics and gynecology 2004;104(5 Pt 2):1184-7.
2004: Wright Jason D; Powell Matthew A; Herzog Thomas J; Mutch David G; Rader Janet S; Gao Feng; Gibb Randall K
Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms.
Gynecologic oncology 2004;94(2):436-41.
2004: Horowitz Neil S; Hua Jun; Gibb Randall K; Mutch David G; Herzog Thomas J
The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Gynecologic oncology 2004;94(1):67-73.
2004: Buttin Barbara M; Powell Matthew A; Mutch David G; Babb Sheri A; Huettner Phyllis C; Edmonston Tina Bocker; Herzog Thomas J; Rader Janet S; Gibb Randall K; Whelan Alison J; Goodfellow Paul J
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.
American journal of human genetics 2004;74(6):1262-9.
2004: Mutch David G; Powell Matthew A; Mallon Mary Ann; Goodfellow Paul J
RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.
American journal of obstetrics and gynecology 2004;190(4):935-42.
2004: Wright Jason D; Powell Matthew A; Mutch David G; Rader Janet S; Gibb Randall K; Huettner Phyllis C; Herzog Thomas J
Synchronous ovarian metastases at the time of laparotomy for colon cancer.
Gynecologic oncology 2004;92(3):851-5.
2004: Buttin Barbara M; Powell Matthew A; Mutch David G; Rader Janet S; Herzog Thomas J; Gibb Randall K; Huettner Phyllis; Edmonston Tina Bocker; Goodfellow Paul J
Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):481-90.
2003: Wright Jason D; Herzog Thomas J; Mutch David G; Gibb Randall K; Rader Janet S; Davila Rosa M; Cohn David E
Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies.
Gynecologic oncology 2003;91(1):134-8.
2003: Wright Jason D; Mutch David G
Treatment of high-risk gestational trophoblastic tumors.
Clinical obstetrics and gynecology 2003;46(3):593-606.
2003: Whitcomb Bradford P; Mutch David G; Herzog Thomas J; Rader Janet S; Gibb Randall K; Goodfellow Paul J
Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2277-87.
2003: Goodfellow Paul J; Buttin Barbara M; Herzog Thomas J; Rader Janet S; Gibb Randall K; Swisher Elizabeth; Look Katherine; Walls Ken C; Fan Ming-Yu; Mutch David G
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(10):5908-13.
2003: Straughn J Michael; Huh Warner K; Orr James W; Kelly F Joseph; Roland Phillip Y; Gold Michael A; Powell Matthew; Mutch David G; Partridge Edward E; Kilgore Larry C; Barnes Mack N; Austin J Maxwell; Alvarez Ronald D
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy.
Gynecologic oncology 2003;89(2):295-300.
2003: Grigsby Perry W; Siegel Barry A; Dehdashti Farrokh; Mutch David G
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
International journal of radiation oncology, biology, physics 2003;55(4):907-13.
2003: Kabbarah Omar; Pinto Karen; Mutch David G; Goodfellow Paul J
Expression profiling of mouse endometrial cancers microdissected from ethanol-fixed, paraffin-embedded tissues.
The American journal of pathology 2003;162(3):755-62.
2003: Noonan Ferrin C; Goodfellow Paul J; Staloch Lora J; Mutch David G; Simon Theodore C
Antisense transcripts at the EMX2 locus in human and mouse.
Genomics 2003;81(1):58-66.
2002: Cohn David E; Horowitz Neil S; Mutch David G; Kim Seok Mo; Manolitsas Tom; Fowler Jeffrey M
Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?
Gynecologic oncology 2002;87(3):243-6.
2002: Horowitz Neil S; Cohn David E; Herzog Thomas J; Mutch David G; Rader Janet S; Bhalla Sanjeev; Gibb Randall K
The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies.
Gynecologic oncology 2002;86(1):79-84.
2002: Horowitz N; Pinto K; Mutch D G; Herzog T J; Rader J S; Gibb R; Bocker-Edmonston T; Goodfellow P J
Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.
Gynecologic oncology 2002;86(1):62-8.
2002: Whelan Alison J; Babb Sheri; Mutch David G; Rader Janet; Herzog Thomas J; Todd Christina; Ivanovich Jennifer L; Goodfellow Paul J
MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
International journal of cancer. Journal international du cancer 2002;99(5):697-704.
2002: Powell Matthew A; Mutch David G; Rader Janet S; Herzog Thomas J; Huang Tim Hui-Ming; Goodfellow Paul J
Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker.
Cancer 2002;94(11):2941-52.
2002: Ivanovich Jennifer; Babb Sheri; Goodfellow Paul; Mutch David; Herzog Thomas; Rader Janet; Whelan Alison
Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1849-56.
2002: Horowitz Neil S; Gibb Randall K; Menegakis Nicole E; Mutch David G; Rader Janet S; Herzog Thomas J
Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients.
Obstetrics and gynecology 2002;99(5 Pt 1):771-6.
2002: Cohn David E; Dehdashti Farrokh; Gibb Randall K; Mutch David G; Rader Janet S; Siegel Barry A; Herzog Thomas J
Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer.
Gynecologic oncology 2002;85(1):179-84.
2002: Swisher Elizabeth M; Cohn David E; Goff Barbara A; Parham Judy; Herzog Thomas J; Rader Janet S; Mutch David G
Use of complementary and alternative medicine among women with gynecologic cancers.
Gynecologic oncology 2002;84(3):363-7.
2002: Mutch David G
Surgical management of ovarian cancer.
Seminars in oncology 2002;29(1 Suppl 1):3-8.
2002: Buttin Barbara M; Herzog Thomas J; Powell Matthew A; Rader Janet S; Mutch David G
Epithelial ovarian tumors of low malignant potential: the role of microinvasion.
Obstetrics and gynecology 2002;99(1):11-7.
2001: Cohn D E; Mutch D G; Herzog T J; Rader J S; Dintzis S M; Gersell D J; Todd C R; Goodfellow P J
Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur.
Genes, chromosomes & cancer 2001;32(4):295-301.
2001: Cohn D E; Mutch D G; Rader J S; Farrell M; Awantang R; Herzog T J
Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.
Gynecologic oncology 2001;83(3):533-6.
2001: Basil J B; Mutch D G
Role of hormone replacement therapy in cancer survivors.
Clinical obstetrics and gynecology 2001;44(3):464-77.
2001: Noonan F C; Mutch D G; Ann Mallon M; Goodfellow P J
Characterization of the homeodomain gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers.
Genomics 2001;76(1-3):37-44.
2001: Grigsby P W; Perez C A; Chao K S; Herzog T; Mutch D G; Rader J
Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes.
International journal of radiation oncology, biology, physics 2001;49(3):733-8.
2001: Swisher E M; Babb S; Whelan A; Mutch D G; Rader J S
Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
The Journal of reproductive medicine 2001;46(2):87-94.
2001: Cohn D; Mutch D; Elbendary A; Rader J; Herzog T; Goodfellow P
No evidence for BCL10 mutation in endometrial cancers with microsatellite instability.
Human mutation 2001;17(2):117-21.
2000: Cohn D E; Swisher E M; Herzog T J; Rader J S; Mutch D G
Radical hysterectomy for cervical cancer in obese women.
Obstetrics and gynecology 2000;96(5 Pt 1):727-31.
2000: Basil J B; Goodfellow P J; Rader J S; Mutch D G; Herzog T J
Clinical significance of microsatellite instability in endometrial carcinoma.
Cancer 2000;89(8):1758-64.
2000: Cohn D E; Basil J B; Venegoni A R; Mutch D G; Rader J S; Herzog T J; Gersell D J; Goodfellow P J
Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability.
Gynecologic oncology 2000;79(1):101-6.
2000: Cohn D E; Babb S; Whelan A J; Mutch D G; Herzog T J; Rader J S; Elbendary A; Goodfellow P J
Atypical clustering of gynecologic malignancies: A family study including molecular analysis of candidate genes.
Gynecologic oncology 2000;77(1):18-25.
1999: Grigsby P W; Perez C A; Chao K S; Elbendary A; Herzog T J; Rader J S; Mutch D G
Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
International journal of radiation oncology, biology, physics 1999;45(3):645-51.
1999: Basil J B; Swisher E M; Herzog T J; Rader J S; Elbendary A; Mutch D G; Goodfellow P J
Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability.
Gynecologic oncology 1999;74(3):395-9.
1999: Perez C A; Grigsby P W; Garipagaoglu M; Mutch D G; Lockett M A
Factors affecting long-term outcome of irradiation in carcinoma of the vagina.
International journal of radiation oncology, biology, physics 1999;44(1):37-45.
1999: Bernhard L M; Klebba P K; Gray D L; Mutch D G
Predictors of persistence of adnexal masses in pregnancy.
Obstetrics and gynecology 1999;93(4):585-9.
1999: Simpkins S B; Bocker T; Swisher E M; Mutch D G; Gersell D J; Kovatich A J; Palazzo J P; Fishel R; Goodfellow P J
MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.
Human molecular genetics 1999;8(4):661-6.
1999: Kost E R; Mutch D G; Herzog T J
Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
Gynecologic oncology 1999;72(3):392-401.
1999: Swisher E M; Peiffer-Schneider S; Mutch D G; Herzog T J; Rader J S; Elbendary A; Goodfellow P J
Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability.
Cancer 1999;85(1):119-26.
1998: Simpkins S B; Peiffer-Schneider S; Mutch D G; Gersell D; Goodfellow P J
PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors.
Gynecologic oncology 1998;71(3):391-5.
1998: Rader J S; Neuman R J; Brady J; Babb S; Temple S; Kost E; Mutch D G; Herzog T J
Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer.
Obstetrics and gynecology 1998;92(4 Pt 1):589-95.
1998: Perez C A; Grigsby P W; Chao C; Galakatos A; Garipagaoglu M; Mutch D; Lockett M A
Irradiation in carcinoma of the vulva: factors affecting outcome.
International journal of radiation oncology, biology, physics 1998;42(2):335-44.
1998: Peiffer-Schneider S; Noonan F C; Mutch D G; Simpkins S B; Herzog T; Rader J; Elbendary A; Gersell D J; Call K; Goodfellow P J
Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval.
Genomics 1998;52(1):9-16.
1998: Swisher E M; Mutch D G; Herzog T J; Rader J S; Kowalski L D; Elbendary A; Goodfellow P J
Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair.
Journal of the Society for Gynecologic Investigation 1998;5(4):210-6.
1998: Perez C A; Grigsby P W; Chao K S; Mutch D G; Lockett M A
Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
International journal of radiation oncology, biology, physics 1998;41(2):307-17.
1998: Chao K S; Leung W M; Grigsby P W; Mutch D G; Herzog T; Perez C A
The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer.
International journal of radiation oncology, biology, physics 1998;40(5):1095-100.
1997: Swisher E M; Mutch D G; Rader J S; Elbendary A; Herzog T J
Topotecan in platinum- and paclitaxel-resistant ovarian cancer.
Gynecologic oncology 1997;66(3):480-6.
1997: Basil J B; Kost E R; Herzog T J; Harris K M; Liapis H; Mutch D G
Recurrent ovarian tumor with low malignant potential and cardiac metastasis.
Obstetrics and gynecology 1997;89(5 Pt 2):854-6.
1997: Kowalski L D; Mutch D G; Herzog T J; Rader J S; Goodfellow P J
Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers.
Genes, chromosomes & cancer 1997;18(3):219-27.
1997: Omura G A; Blessing J A; Vaccarello L; Berman M L; Clarke-Pearson D L; Mutch D G; Anderson B
Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):165-71.
1996: Arlt M F; Herzog T J; Mutch D G; Gersell D J; Liu H; Goodfellow P J
Frequent deletion of chromosome 1p sequences in an aggressive histologic subtype of endometrial cancer.
Human molecular genetics 1996;5(7):1017-21.
1996: Moley K H; Massad L S; Mutch D G
Pelvic inflammatory disease. Correlation of severity with CA-125 levels.
The Journal of reproductive medicine 1996;41(5):341-6.
1996: Teefey S A; Stahl J A; Middleton W D; Huettner P C; Bernhard L M; Brown J J; Hildebolt C F; Mutch D G
Local staging of endometrial carcinoma: comparison of transvaginal and intraoperative sonography and gross visual inspection.
AJR. American journal of roentgenology 1996;166(3):547-52.
1996: Arlt M F; Herzog T J; Mutch D G; Goodfellow P J
Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancer.
Gynecologic oncology 1996;60(2):308-12.
1996: Chao C K; Grigsby P W; Perez C A; Mutch D G; Herzog T; Camel H M
Medically inoperable stage I endometrial carcinoma: a few dilemmas in radiotherapeutic management.
International journal of radiation oncology, biology, physics 1996;34(1):27-31.
1996: Herzog T J; Horiuchi T K; Williams S; Camel H M; Mutch D G
Growth modulatory effects of granulocyte-macrophage colony-stimulating factor on human cell lines derived from gynecologic malignancies.
American journal of obstetrics and gynecology 1996;174(1 Pt 1):161-8.
1996: Kost E R; Herzog T J; Adler L M; Williams S; Mutch D G
The role of tumor necrosis factor receptors in tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines.
American journal of obstetrics and gynecology 1996;174(1 Pt 1):145-53.
1995: Peiffer S L; Bartsch D; Whelan A J; Mutch D G; Herzog T J; Goodfellow P J
Low frequency of CDKN2 mutation in endometrial carcinomas.
Molecular carcinogenesis 1995;13(4):210-2.
1995: Lonky N M; Mann W J; Massad L S; Mutch D G; Blanco J S; Vasilev S A; Finan M A; Scotti R J
Ability of visual tests to predict underlying cervical neoplasia. Colposcopy and speculoscopy.
The Journal of reproductive medicine 1995;40(7):530-6.
1995: Herzog T J; Williams S; Adler L M; Rader J S; Kubiniec R T; Camel H M; Mutch D G
Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasia.
Gynecologic oncology 1995;57(3):286-93.
1995: Peiffer S L; Herzog T J; Tribune D J; Mutch D G; Gersell D J; Goodfellow P J
Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.
Cancer research 1995;55(9):1922-6.
1995: Perez C A; Grigsby P W; Camel H M; Galakatos A E; Mutch D; Lockett M A
Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.
International journal of radiation oncology, biology, physics 1995;31(4):703-16.
1994: Adler L M; Herzog T J; Williams S; Rader J S; Mutch D G
Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines.
Cancer 1994;74(7):1891-8.
1993: Massad L S; Vogler G; Herzog T J; Mutch D G
Correlates of length of stay in gynecologic oncology patients undergoing inpatient surgery.
Gynecologic oncology 1993;51(2):214-8.
1993: Massad L S; Reiss C K; Mutch D G; Haskel E J
Familial peripartum cardiomyopathy after molar pregnancy.
Obstetrics and gynecology 1993;81(5 ( Pt 2)):886-8.
1993: Massad L S; Lonky N M; Mutch D G; Mann W J; Blanco J S; Vasilev S A; Finan M A; Scotti R J
Use of speculoscopy in the evaluation of women with atypical Papanicolaou smears. Improved cost effectiveness by selective colposcopy.
The Journal of reproductive medicine 1993;38(3):163-9.
1992: Williams S; Mutch D G; Xu L; Collins J L
Divergent effects of taxol on tumor necrosis factor-alpha-mediated cytolysis of ovarian carcinoma cells.
American journal of obstetrics and gynecology 1992;167(6):1870-6.
1992: Herzog T J; Nelson P K; Mutch D G; Wright W D; Kao M S; Collins J L
Effects of radiation on TNF alpha-mediated cytolysis of cell lines derived from cervical carcinomas.
Gynecologic oncology 1992;47(2):196-202.
1992: Mutch D G; Herzog T J; Chen C A; Collins J L
The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.
Gynecologic oncology 1992;47(1):28-33.
1992: Pearlstone A C; Grigsby P W; Mutch D G
High rates of atypical cervical cytology: occurrence and clinical significance.
Obstetrics and gynecology 1992;80(2):191-5.
1992: Mutch D G; Powell C B; Kao M S; Collins J L
Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
Cancer research 1992;52(4):866-72.
1991: Massad L S; Mutch D G; Kao M S; Powell C B; Collins J L
Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies.
Cancer immunology, immunotherapy : CII 1991;33(3):183-8.
1990: Mutch D G; Massad L S; Kao M S; Collins J L
Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignancies.
American journal of obstetrics and gynecology 1990;163(6 Pt 1):1920-4.
1990: Massad L S; Mutch D G; Powell C B; Kao M S; Collins J L
Expression of a resistance mechanism in ovarian and cervical carcinoma cells prevents their lysis by gamma-interferon.
Cancer research 1990;50(16):4923-8.
1990: Powell C B; Mutch D G; Kao M S; Collins J L
Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatin.
Clinical and experimental immunology 1990;79(3):424-9.
1990: Powell C B; Mutch D G; Kao M S; Kao J W; Perry D L; Westphale E; Collins J L
Dexamethasone used as an antiemetic in chemotherapy protocols inhibits natural cytotoxic (NC) cell activity.
Cancer 1990;65(3):466-72.
1990: Powell C B; Mutch D G; Massad L S; Kao M S; Collins J L
Common expression of a tumor necrosis factor resistance mechanism among gynecological malignancies.
Cancer immunology, immunotherapy : CII 1990;32(2):131-6.
1989: Mutch D G; Powell C B; Kao M S; Collins J L
In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatin.
Gynecologic oncology 1989;34(3):328-33.
1988: Gersell D J; Mazoujian G; Mutch D G; Rudloff M A
Small-cell undifferentiated carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases.
The American journal of surgical pathology 1988;12(9):684-98.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

David Mutch

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Procedures

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of David Mutch (preview)

All Publications